Bicara Therapeutics Inc.
SEC 4 · Filed
0001628280-25-059045Accepted
Applies to the EDGAR acceptance time.
Other time zone
Insider transactionsEvent date Dec 26, 2025
- Security
- Stock Option (Right to Buy)
- Shares
-
25,000
- Price per share
-
0.00
Structured facts
{
"code": "M",
"date": "2025-12-26",
"direction": "D",
"exercise_price": "4.4369",
"expiration": "2032-10-04",
"footnotes": {
"F2": "The shares underlying this option vest in sixteen equal quarterly installments following October 4, 2022, subject to the Reporting Person\u0027s continued service on each such vesting date."
},
"owners": [
{
"cik": "0002034665",
"name": "Cohlhepp Ryan",
"roles": [
"director",
"officer"
],
"title": "President and COO"
}
],
"ownership": "D",
"post_shares": "39909",
"price": "0",
"row": 1,
"rule_10b5_1": "0",
"security": "Stock Option (Right to Buy)",
"shares": "25000",
"table": "II",
"underlying_security": "Common Stock",
"underlying_shares": "25000"
}Insider transactionsEvent date Dec 26, 2025
- Security
- Common Stock
- Shares
-
25,000
- Price per share
-
4.44
Reported 4.4369
Structured facts
{
"code": "M",
"date": "2025-12-26",
"direction": "A",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F1": "This is an ISO exercise and hold to acquire and retain direct share ownership of the issuer."
},
"owners": [
{
"cik": "0002034665",
"name": "Cohlhepp Ryan",
"roles": [
"director",
"officer"
],
"title": "President and COO"
}
],
"ownership": "D",
"post_shares": "214141",
"price": "4.4369",
"row": 1,
"rule_10b5_1": "0",
"security": "Common Stock",
"shares": "25000",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}